Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 23;6(9-10):368-370.
doi: 10.18632/oncoscience.485. eCollection 2019 Sep.

Menin: Expanding and dichotomous roles in cancer

Bryson W Katona  1   2 , Rebecca A Glynn  2 , Taylor A Hojnacki  2 , Xianxin Hua  2
Affiliations

Menin: Expanding and dichotomous roles in cancer

Bryson W Katona et al. Oncoscience. .
No abstract available

Keywords: EGFR inhibitor; SKP2; colorectal cancer; menin.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no potential conflicts of interest.

Figures

Figure 1
Figure 1. The combination of a menin inhibitor (MI) and small molecule EGFR inhibitor (iEGFR) synergistically suppress CRC through repression of SKP2 transcription
See this image and copyright information in PMC

References

    1. Li JW, Hua X, Reidy-Lagunes D, Untch BR. MENIN loss as a tissue-specific driver of tumorigenesis. Mol Cell Endocrinol. 2018;469:98–106. doi: 10.1016/j.mce.2017.09.032. - DOI - PMC - PubMed
    1. Matkar S, Katona BW, Hua X. Harnessing the hidden antitumor power of the MLL-AF4 oncogene to fight leukemia. Cancer Cell. 2014;25:411–13. doi: 10.1016/j.ccr.2014.03.028. - DOI - PMC - PubMed
    1. Borkin D, He S, Miao H, Kempinska K, Pollock J, Chase J, Purohit T, Malik B, Zhao T, Wang J, Wen B, Zong H, Jones M, et al. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015;27:589–602. doi: 10.1016/j.ccell.2015.02.016. - DOI - PMC - PubMed
    1. Malik R, Khan AP, Asangani IA, Cieślik M, Prensner JR, Wang X, Iyer MK, Jiang X, Borkin D, Escara-Wilke J, Stender R, Wu YM, Niknafs YS, et al. Targeting the MLL complex in castration-resistant prostate cancer. Nat Med. 2015;21:344–52. doi: 10.1038/nm.3830. - DOI - PMC - PubMed
    1. Katona BW, Glynn RA, Paulosky KE, Feng Z, Davis CI, Ma J, Berry CT, Szigety KM, Matkar S, Liu Y, Wang H, Wu Y, He X, et al. Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription. Cancer Res. 2019;79:2195–207. doi: 10.1158/0008-5472.CAN-18-2133. - DOI - PMC - PubMed